Literature DB >> 3106477

Dissociation between lymphocyte activation for proliferation and for the capacity to adoptively transfer uveoretinitis.

G M Fox, T M Redmond, B Wiggert, T Kuwabara, G J Chader, I Gery.   

Abstract

We have shown previously that immunization with bovine interphotoreceptor retinoid-binding protein (IRBP) induces in rats severe eye disease, experimental autoimmune uveoretinitis (EAU). This study examined the uveitogenic capacity of IRBP of another species, the monkey, and tested the cross-antigenicity between these two proteins by a battery of immunological assays. Monkey IRBP was found to be approximately 20 times less uveitogenic in Lewis rats than bovine IRBP. High levels of cross-reactivity between bovine and monkey IRBP were demonstrated by antibodies as measured by the enzyme-linked immunosorbent assay, and by the radiometric ear test of delayed-type hypersensitivity, by using rats immunized with either one of the IRBP. On the other hand, lymphocytes from these rats failed to detect the cross-reactivity between the two IRBP by the proliferation response in culture. Yet, such lymphocytes did recognize the nonimmunizing IRBP when activated in culture for acquiring the capacity to adoptively transfer EAU into naive recipients. The data are discussed with regard to the limited usefulness of the lymphocyte proliferation assay for detection of immunopathogenic processes and the role of cross-reacting antigens in initiation of autoimmune responses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106477

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.

Authors:  Yong Peng; Gencheng Han; Hui Shao; Yali Wang; Henry J Kaplan; Deming Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

2.  Suppression of actively induced experimental autoimmune uveoretinitis by CD4+ T cells.

Authors:  E Uchio; M Kijima; M Ishioka; S Tanaka; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-02       Impact factor: 3.117

3.  The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU).

Authors:  Deming Sun; Dongchun Liang; Henry J Kaplan; Hui Shao
Journal:  Cytokine       Date:  2015-03-02       Impact factor: 3.861

4.  Analysis of the uveitogenic determinant in repeat structure of retinal interphotoreceptor retinoid-binding protein (IRBP).

Authors:  H Inoue; M Takeuchi; T Tanaka; M Usui; S Ando; O Taguchi
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

5.  Characterisation of passively transferred antigen arthritis induced by methylated bovine serum albumin in the rat: effect of FK 506 on arthritis development.

Authors:  R J Griffiths; S W Li; M E Mather
Journal:  Agents Actions       Date:  1992-05

6.  Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells.

Authors:  Yan Cui; Hui Shao; Chen Lan; Hong Nian; Rebecca L O'Brien; Willi K Born; Henry J Kaplan; Deming Sun
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

7.  Fine specificity of CD4+ T cell responses to the dominant encephalitogenic PLP 139-151 peptide in SJL/J mice.

Authors:  B L McRae; S D Miller
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

8.  Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis.

Authors:  Tingyu Qin
Journal:  Mol Vis       Date:  2011-12-29       Impact factor: 2.367

9.  Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP).

Authors:  H Sanui; T M Redmond; S Kotake; B Wiggert; L H Hu; H Margalit; J A Berzofsky; G J Chader; I Gery
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

10.  A pathogenic autoimmune process targeted at a surrogate epitope.

Authors:  A T Kozhich; Y Kawano; C E Egwuagu; R R Caspi; R K Maturi; J A Berzofsky; I Gery
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.